Table 1.
Participant Demographics
| Characteristic | Blood
|
Orbit
|
Lacrimal Gland
|
|||
|---|---|---|---|---|---|---|
| Normal | Sarcoidosis | Normal | Sarcoidosis | Normal | Sarcoidosis | |
| No. of samples | 12 | 12 | 6 | 7 | 6 | 5 |
|
| ||||||
| Demographics | ||||||
|
| ||||||
| Age, mean (SD), y | 53.9 (12.2) | 48.8 (21.4) | 69.7 (9.8) | 48.8 (14.7) | 68.2 (9.7) | 31.4 (15.4) |
|
| ||||||
| Female sex, No. (%) | 9 (75) | 8 (67) | 5 (83) | 5 (71) | 5 (83) | 4 (80) |
|
| ||||||
| Disease duration prior to biopsy, mean (SD), mo | NA | NA | NA | 8.8 (7.0) | NA | 2.1 (1.4) |
|
| ||||||
| Race, No. (%) | ||||||
|
| ||||||
| White | 11 (92) | 10 (83) | 3 (50) | 3 (43) | 6 (100) | 1 (20) |
|
| ||||||
| African American | 0 | 1 (8) | 1 (17) | 2 (29) | 0 | 2 (40) |
|
| ||||||
| American Indian | 0 | 0 | 1 (17) | 0 | 0 | 0 |
|
| ||||||
| Asian | 1 (8) | 1 (8) | 1 (17) | 0 | 0 | 0 |
|
| ||||||
| Unknown | 0 | 0 | 0 | 2 (29) | 0 | 2 (40) |
|
| ||||||
| Prednisone therapy at time of biopsy, No. (%) | 0 | 0 | 0 | 1 (20)a | 0 | 1 (25)b |
Abbreviation: NA, not available.
a
There were no data on prednisone use for 2 patients.
b
There were no data on prednisone use for 1 patient.